Drug Pricing Fears Erase Biotech Stock Gains for the Year
Sep 29, 2015, 10:42 AM
by
Michael Croft
The Street | Anger over a price hike at Turing Pharmaceuticals and a Congressional letter to Valeant have dealt a blow to biotech stocks that many observers already fretted were sharply overvalued.
September 29, 2015 | Anger over a price hike at Turing Pharmaceuticals and a Congressional letter to Valeant have dealt a blow to biotech stocks that many observers already fretted were sharply overvalued. The Street